Augmenix picks up $6 mln
Waltham, Massachusetts-based Augmenix, a developer of radiation oncology products, has raised $6 million in Series E funding. The investors were not named.
13 July 2016•1 min read
Waltham, Massachusetts-based Augmenix, a developer of radiation oncology products, has raised $6 million in Series E funding. The investors were not named.
